Phase I/II Study of Pyrazoloacridine (PZA) [PD 115934] in Adults With Newly Diagnosed Glioblastoma Multiforme.
Phase of Trial: Phase I/II
Latest Information Update: 23 May 2018
At a glance
- Drugs PD 115934 (Primary)
- Indications Astrocytoma; Glioblastoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 02 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2012 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
- 21 Sep 2005 New trial record.